2020 Molecular Blood Typing, Grouping and Infectious Disease NAT Market - Abbott, Diagast, LabCorp & Siemens Healthineers - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 4, 2020--
The “2020 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Supplier Shares by Country, Screening Assays, Strategic Profiles of Leading Competitors” report has been added to ResearchAndMarkets.com’s offering.
This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.
The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
For more information about this report visit https://www.researchandmarkets.com/r/3vrw1m
View source version on businesswire.com:https://www.businesswire.com/news/home/20200204005594/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES
SOURCE: Research and Markets
Copyright Business Wire 2020.
PUB: 02/04/2020 08:27 AM/DISC: 02/04/2020 08:27 AM